These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25268103)

  • 21. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistant hypertension: comparing hemodynamic management to specialist care.
    Taler SJ; Textor SC; Augustine JE
    Hypertension; 2002 May; 39(5):982-8. PubMed ID: 12019280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural cardiovascular changes in essential hypertension. Studies on the effect of antihypertensive therapy.
    Dahlöf B
    Blood Press Suppl; 1992; 6():1-75. PubMed ID: 1345261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Squat-stand test response following 10 consecutive episodes of head-up tilt.
    Berry NM; Rickards CA; Newman DG
    Aviat Space Environ Med; 2006 Nov; 77(11):1125-30. PubMed ID: 17086764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial hemodynamic measurements allow better blood pressure control than clinical judgment in those with refractory hypertension.
    Basile J
    J Clin Hypertens (Greenwich); 2002; 4(6):434-5. PubMed ID: 12461310
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term haemodynamic effects of enalapril at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P
    Scand J Urol Nephrol Suppl; 1984; 79():87-91. PubMed ID: 6089323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial.
    Sakata Y; Shiba N; Takahashi J; Miyata S; Nochioka K; Miura M; Takada T; Saga C; Shinozaki T; Sugi M; Nakagawa M; Sekiguchi N; Komaru T; Kato A; Fukuchi M; Nozaki E; Hiramoto T; Inoue K; Goto T; Ohe M; Tamaki K; Ibayashi S; Ishide N; Maruyama Y; Tsuji I; Shimokawa H; ;
    Eur Heart J; 2015 Apr; 36(15):915-23. PubMed ID: 25637937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
    Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E
    Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of acute and chronic angiotensin converting enzyme inhibition by spirapril on cardiovascular regulation in essential hypertensive patients. Assessment by spectral analysis and haemodynamic measurements.
    Veerman DP; Douma CE; Jacobs MC; Thien T; Van Montfrans GA
    Br J Clin Pharmacol; 1996 Jan; 41(1):49-56. PubMed ID: 8824693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients.
    Guasti L; Gaudio G; Lupi A; D'Avino M; Sala C; Mugellini A; Vulpis V; Felis S; Sarzani R; Vanasia M; Maffioli P; Derosa G
    Drug Des Devel Ther; 2017; 11():2293-2300. PubMed ID: 28831241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reverse remodeling and improved function by antihypertensive treatment in hypertensive patients with coronary artery disease.
    Yui Y; Kodama K; Hirayama A; Nishio R; Iwanaga Y; Nonogi H; Haze K; Sumiyoshi T; Yui N; Hosoda S; Kawai C;
    J Hypertens; 2010 Jan; 28(1):178-85. PubMed ID: 19927011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the optic disc structure with the use of antihypertensive medications: the thessaloniki eye study.
    Harris A; Topouzis F; Wilson MR; Founti P; Kheradiya NS; Anastasopoulos E; Gong G; Yu F; Jonescu-Cuypers CP; Pappas T; Koskosas A; Coleman AL
    J Glaucoma; 2013 Sep; 22(7):526-31. PubMed ID: 22411020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A meta-analysis of randomized controlled trials assessing the impact of beta-blockers on arterial stiffness, peripheral blood pressure and heart rate.
    Niu W; Qi Y
    Int J Cardiol; 2016 Sep; 218():109-117. PubMed ID: 27232921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
    Takeyama K; Minato H; Nakatsuji K; Suzuki H; Nose I; Oka M; Hosoki K; Hatano N; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):69-73. PubMed ID: 3513779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.